| - | | Peptide Therapeutic Agent of Autoimmune Diseases and Inflammatory Diseases | 김순선, 서창희, 정재연 |
| 2017 | | Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma | 김순선, 김진우, 노충균, 신성재, 양민재, 원제환, 이기명, 정재연, 조성원, 조효정, 지재훈 |
| 2018 | | Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma | 김보현, 김순선, 김재근, 김진우, 김현지, 원제환, 이제희, 정재연, 조성원, 조효정 |
| 2013 | | Polymorphisms near interleukin 28B gene are not associated with hepatitis B virus clearance, hepatitis B e antigen clearance and hepatocellular carcinoma occurrence. | 정재연, 조성원 |
| 2010 | | Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis | 김재근, 정재연, 조성원 |
| 2008 | | Problems faced by Korean patients with chronic liver disease and the role of the Korean Association for the Study of the Liver -Emphases on social discrimination, insufficiency of reimbursement coverage, and deficiency of the welfare system - | 정재연 |
| 2014 | | Profiling of exome mutations associated with progression of HBV-related hepatocellular carcinoma. | 김순선, 안선주, 우현구, 정재연, 조성원, 조효정 |
| 2014 | | Prognostic significance of catalase expression and its regulatory effects on hepatitis B virus X protein (HBx) in HBV-related advanced hepatocellular carcinomas. | 왕희정, 이영수, 정재연, 조혜성 |
| 2021 | | Prognostic value of alpha-fetoprotein in patients who achieve a complete response to transarterial chemoembolization for hepatocellular carcinoma | 김순선, 정재연, 조효정 |
| 2008 | | Prospective Evaluation of Ultrathin Transnasal Esophagogastroduodenoscopy: Its Feasibility, Safety and Tolerance | 김진홍, 신성재, 유병무, 이광재, 이기명, 정성현, 정재연, 황재철 |
| 2004 | | Protective mechanism of epigallocatechin-3-gallate against Helicobacter pylori-induced gastric epithelial cytotoxicity via the blockage of TLR-4 signaling. | 김진홍, 이광재, 이기명, 정재연, 함기백 |
| 2013 | | Radiofrequency ablation of metastatic liver masses: recurrence patterns and prognostic factors based on radiologic features. | 김재근, 김태희, 박미진, 이기명, 정재연 |
| 2007 | | RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population. | 김진홍, 정재연, 조성원 |
| 2017 | | Reduced impact of renal failure on the outcome of patients with alcoholic liver disease undergoing liver transplantation | 정재연 |
| 2013 | | Relevance of interleukin-10RB to chronic hepatitis B virus infection and biological activities of interferon-λ and interleukin-22. | 김경민, 김순선, 박선, 정재연, 조성원, 최용준 |
| 2015 | | Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci of STAT4 and HLA-DQ in a Korean population. | 정재연, 조성원 |
| 2017 | | Response to Dr Giannini et al | 김순선, 정재연, 조성원, 조효정 |
| 2012 | | Revision and update on clinical practice guideline for liver cirrhosis | 김재근, 정재연, 조성원 |
| 2012 | | Risk factors for perforations associated with endoscopic submucosal dissection in gastric lesions: emphasis on perforation type | 김동훈, 김진홍, 신성재, 유병무, 유준환, 이광재, 이기명, 임선교, 정재연, 조성원, 황재철 |
| 2011 | | Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels. | 김영배, 정재연, 조성원 |
| 2012 | | Serum markers for predicting significant necroinflammatory activity in patients with chronic hepatitis B | 김순선, 김영배, 정재연, 조성원 |
| 2014 | | Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B | 김순선, 김영배, 박주한, 안선주, 정재연, 조성원, 조효정 |
| 2010 | | Single nucleotide polymorphisms and the Linkage disequilibrium at the LDL receptor gene in Koreans | 정재연, 조성원 |
| 2010 | | Single nucleotide polymorphisms and the linkage disequilibrium at the LDL receptor gene in Koreans. | 정재연, 조성원 |
| 2008 | | Sorafenib in Advanced Hepatocellular Carcinoma | 정재연 |
| 2019 | | Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial | 정재연 |
| 2021 | | SPP1 biomarker for predicting the response of anticancer drugs to liver cancer and use thereof | 김순선, 은정우, 정재연, 조효정 |
| 2005 | | Survival benefits of intra-arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis. | 김재근, 김진홍, 왕희정, 원제환, 이기명, 정재연, 조성원, 함기백 |
| 2018 | | Tamoxifen-Induced Non-alcoholic Steatohepatitis Cirrhosis | 김순선, 김영배, 정재연, 조성원 |
| 2015 | | Tenofovir-based rescue therapy in chronic hepatitis B patients with suboptimal responses to adefovir with prior lamivudine resistance. | 김순선, 신성재, 유병무, 정재연, 조성원, 조효정 |
| 2010 | | The prevalence of significant fibrosis in chronic hepatitis B patients with ALT | 김영배, 정재연, 조성원 |
| 2011 | | The usefulness of liver stiffness measurement using FibroScan in chronic hepatitis C in South Korea: a multicenter, prospective study | 이명희, 정재연, 조성원 |
| 2008 | | Topics related to hepatic fibrosis | 정재연 |
| 2010 | | Tracking of transplanted mesenchymal stem cells labeled with fluorescent magnetic nanoparticle in liver cirrhosis rat model with 3-T MRI. | 김선용, 김재근, 김태희, 박태준, 정재연 |
| 2007 | | Treatment of Patients with Non-alcoholic Fatty Liver Disease | 정재연 |
| 2020 | | Use for detection of hepatocellular carcinoma specific MLH1 circulating tumor DNA mutation | 김순선, 은정우, 정재연, 조효정 |
| 2011 | | Usefulness of multiple biomarkers for the prediction of significant fibrosis in chronic hepatitis B. | 김영배, 정재연, 조성원 |
